ADLM Guidance Document on the Measurement and Reporting of Lipids and Lipoproteins

J Appl Lab Med. 2024 Sep 3;9(5):1040-1056. doi: 10.1093/jalm/jfae057.

Abstract

Background: The accurate measurement of blood lipids and lipoproteins is crucial for the clinical management of atherosclerotic disease risk. Despite progress in standardization, there are still significant variations in pre-analytical requirements, methods, nomenclature, and reporting work flows.

Content: The guidance document aims to improve standardization of clinical lipid testing work flows. It provides recommendations for the components of the lipid panel, fasting requirements, reporting of results, and specific recommendations for non-high-density lipoprotein cholesterol (non-HDL-C), low-density lipoprotein cholesterol (LDL-C), lipoprotein(a) [Lp(a)], apolipoprotein B (apo B), point-of-care lipid testing, and LDL subfraction testing.

Summary: Lipid panels should always report non-HDL-C and LDL-C calculations if possible. Fasting is not routinely required except in specific cases. Modern equations should be utilized for LDL-C calculation. These equations allow for LDL-C reporting at elevated concentrations of triglycerides and obviate the need for direct measured LDL-C in most cases.

Publication types

  • Practice Guideline

MeSH terms

  • Apolipoproteins B / blood
  • Atherosclerosis / blood
  • Atherosclerosis / diagnosis
  • Cholesterol, LDL / blood
  • Humans
  • Lipids* / analysis
  • Lipids* / blood
  • Lipoprotein(a) / blood
  • Lipoproteins* / analysis
  • Lipoproteins* / blood

Substances

  • Lipoproteins
  • Lipids
  • Cholesterol, LDL
  • Apolipoproteins B
  • Lipoprotein(a)